Clinical Trial Update: BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets [Phase 1]

View source ↗

Summary

Phase 1 trial of BMTP-11 for castration-resistant prostate cancer with bone metastases has completed; the update does not provide specific results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• BMTP-11

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED